Aspire Biopharma, Inc. (NASDAQ:PWUP) | WebDisclosure

Basculer en Français

9480	Companies
185523	Keywords
117909	Articles
99369	Press releases

Headlines Articles Press releases Aspire Biopharma, Inc.

Home
Companies
Aspire Biopharma, Inc.

BRIEF

published on 04/29/2025 at 14:35, 7 months 6 days ago

Aspire Biopharma reçoit l'approbation du comité d'éthique de la recherche (IRB) pour un essai sur l'aspirine à action rapide

Essai Clinique Procédure Accélérée De La FDA Aspirine Sublinguale Approbation De L'IRB Pharmacocinétique
BRIEF

published on 04/29/2025 at 14:35, 7 months 6 days ago

Aspire Biopharma Receives IRB Approval for Rapid-Acting Aspirin Trial

Clinical Trial IRB Approval Sublingual Aspirin Pharmacokinetics FDA Fast-Track
PRESS RELEASE

published on 04/29/2025 at 14:30, 7 months 6 days ago

Aspire Biopharma Holdings, Inc., Announces Institutional Review Board Approval for In-Human Clinical Trial of an Oral Transmucosal Fast-Acting High-Dose Aspirin Formulation
Aspire Biopharma achieves IRB approval for Phase I clinical trial of fast-acting high-dose aspirin formulation, targeting rapid drug delivery and enhanced bioavailability for suspected acute myocardial infarction treatment

Phase I Clinical Trial IRB Approval Aspire Biopharma Acute Myocardial Infarction Fast-acting Aspirin
BRIEF

published on 04/14/2025 at 14:35, 7 months 21 days ago

Aspire Biopharma participera à la conférence Emerging Growth

Conférence Sur La Croissance Émergente Approbation De La FDA Aspire Biopharma Aspirine À Haute Dose Étude Clinique De Phase 1
BRIEF

published on 04/14/2025 at 14:35, 7 months 21 days ago

Aspire Biopharma to Present at Emerging Growth Conference

FDA Approval Emerging Growth Conference Phase 1 Clinical Study Aspire Biopharma High-dose Aspirin
PRESS RELEASE

published on 04/14/2025 at 14:30, 7 months 21 days ago

Aspire Biopharma Holdings, Inc., to Present at the Emerging Growth Conference on Thursday, April 17
Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) to present at the Emerging Growth Conference on April 17, 2025, showcasing their patent-pending drug delivery technology

Emerging Growth Conference Clinical Trial Drug Delivery Patent-pending Technology Aspire Biopharma
BRIEF

published on 04/11/2025 at 14:35, 7 months 24 days ago

Aspire Biopharma lance la production d'un complément pré-entraînement

Technologie Sublinguale Marché Du Fitness Aspire Biopharma Supplément Pré-entraînement Tests Consommateurs
BRIEF

published on 04/11/2025 at 14:35, 7 months 24 days ago

Aspire Biopharma Begins Production of Pre-Workout Supplement

Sublingual Technology Fitness Market Aspire Biopharma Pre-workout Supplement Consumer Testing
PRESS RELEASE

published on 04/11/2025 at 14:30, 7 months 24 days ago

Aspire Biopharma Holdings, Inc., Commences Initial Production of its Pre-Workout Performance Supplement
Aspire Biopharma initiates production of new pre-workout supplement with innovative technology and plans consumer testing. Increasing demand for fitness supplements drives growth

Health And Wellness Industry Aspire Biopharma Pre-workout Supplement Consumer Testing Fitness Supplements
BRIEF

published on 04/09/2025 at 14:35, 7 months 26 days ago

Aspire Biopharma lance un essai de phase 1 pour l'aspirine à haute dose

Procédure Accélérée De La FDA Essai De Phase 1 Aspire Biopharma Aspirine À Haute Dose Formulation Sublinguale

Accesswire

Published on 12/05/2025 at 18:20, 7 minutes ago

NuRAN Announces Intention to Complete Consolidation in Preparation to the Restructuring Transaction
Published on 12/05/2025 at 18:00, 27 minutes ago

SMX: A New Supply Chain Reality in the World's Four Largest Markets
Published on 12/05/2025 at 17:15, 1 hour 12 minutes ago

TRX GOLD Attending the 3rd Annual DealFlow Discovery Conference
Published on 12/05/2025 at 17:00, 1 hour 27 minutes ago

Three Trillion-Dollar Frontiers, One Technology: How SMX Is Everywhere at Once
Published on 12/05/2025 at 16:00, 2 hours 27 minutes ago

SMX Didn't Change Its Story; The World Finally Connected the Dots

View all ACCESSWIRE

EQS Group

Published on 12/05/2025 at 18:15, 11 minutes ago

Completion of merger to form Helvetia Baloise Holding Ltd
Published on 12/05/2025 at 17:51, 35 minutes ago

Issue of Equity
Published on 12/05/2025 at 17:46, 40 minutes ago

Booster Precision Components Holding GmbH announces the successful completion of its Written Procedure to amend and waive certain terms under the terms and conditions of the Bonds
Published on 12/05/2025 at 17:00, 1 hour 26 minutes ago

EQS-Adhoc: The NAGA Group AG adjusts guidance for financial year 2025 following continued low volatility and weaker year-end performance
Published on 12/05/2025 at 16:25, 2 hours 1 minute ago

4YFN26 Awards: Meet the Top 20 startups building the future

Les Echos

Published on 12/05/2025 at 17:18, 1 hour 9 minutes ago

La vidéo de la réunion de présentation des résultats 2024-2025 du 5 décembre 2025 est disponible
Published on 12/05/2025 at 17:18, 1 hour 9 minutes ago

The video of the 2024-2025 results presentation meeting on December 5, 2025, is available
Published on 12/05/2025 at 15:10, 3 hours 16 minutes ago

Mersen: Number of shares and voting rights as of November 30, 2025
Published on 12/05/2025 at 15:10, 3 hours 16 minutes ago

Mersen : nombre d'actions et de droits de vote au 30 novembre 2025
Published on 12/05/2025 at 13:58, 4 hours 28 minutes ago

RELATIF A LA MISE A DISPOSITION DU PUBLIC DE LA NOTE D'INFORMATION ET DES INFORMATIONS RELATIVES AUX CARACTERISTIQUES, NOTAMMENT JURIDIQUES, FINANCIERES ET COMPTABLES DE LEGRAND FRANCE

View all LES ECHOS COMFI WIRE